Corticosteroids in severe COVID-19: a critical view of the evidence.
作者信息
De Backer Daniel, Azoulay Elie, Vincent Jean-Louis
机构信息
Department of Intensive Care, CHIREC Hospitals, Université Libre de Bruxelles, Brussels, Belgium.
Medical Intensive Care Unit, Saint Louis University Hospital, APHP, Paris, France.
出版信息
Crit Care. 2020 Oct 29;24(1):627. doi: 10.1186/s13054-020-03360-0.
Abstract
摘要
相似文献
1
Corticosteroids in severe COVID-19: a critical view of the evidence.
Crit Care. 2020 Oct 29;24(1):627. doi: 10.1186/s13054-020-03360-0.
2
Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials.
Trials. 2020 Aug 24;21(1):734. doi: 10.1186/s13063-020-04641-3.
3
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
4
WHO recommends corticosteroids for patients with severe or critical COVID-19.
Ann Intern Med. 2021 Jan;174(1):JC2. doi: 10.7326/ACPJ202101190-002. Epub 2021 Jan 5.
5
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
CMAJ. 2020 Jul 6;192(27):E756-E767. doi: 10.1503/cmaj.200645. Epub 2020 May 14.
6
COVID-19 pneumonia: do not leave the corticosteroids behind!
Future Microbiol. 2021 Mar;16:317-322. doi: 10.2217/fmb-2020-0199. Epub 2021 Mar 12.
7
The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis.
PLoS One. 2021 Apr 21;16(4):e0249481. doi: 10.1371/journal.pone.0249481. eCollection 2021.
8
Systemic corticosteroids for the treatment of COVID-19.
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963.
9
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
Trials. 2020 Jul 9;21(1):632. doi: 10.1186/s13063-020-04575-w.
10
Corticosteroids for Patients With Coronavirus Disease 2019 (COVID-19) With Different Disease Severity: A Meta-Analysis of Randomized Clinical Trials.
J Cardiothorac Vasc Anesth. 2021 Feb;35(2):578-584. doi: 10.1053/j.jvca.2020.11.057. Epub 2020 Nov 28.
引用本文的文献
1
The Efficacy of High-Dose Pulse Therapy vs. Low-Dose Intravenous Methylprednisolone on Severe to Critical COVID-19 Clinical Outcomes: A Randomized Clinical Trial.
Iran J Pharm Res. 2023 Aug 26;22(1):e137838. doi: 10.5812/ijpr-137838. eCollection 2023 Jan-Dec.
2
Methylprednisolone pulse therapy for critically ill patients with COVID-19: a cohort study.
Acute Crit Care. 2023 Feb;38(1):57-67. doi: 10.4266/acc.2022.00941. Epub 2023 Feb 7.
3
Effectiveness of Borage plus syrup on COVID-19 patients in intensive care units.
Front Nutr. 2022 Nov 15;9:975937. doi: 10.3389/fnut.2022.975937. eCollection 2022.
4
From Cytokine Storm to Cytokine Breeze: Did Lessons Learned from Immunopathogenesis Improve Immunomodulatory Treatment of Moderate-to-Severe COVID-19?
Biomedicines. 2022 Oct 18;10(10):2620. doi: 10.3390/biomedicines10102620.
5
Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial.
Clin Transl Sci. 2022 Jul;15(7):1796-1804. doi: 10.1111/cts.13297. Epub 2022 Jun 15.
6
Early Corticosteroid Therapy May Increase Ventilator-Associated Lower Respiratory Tract Infection in Critically Ill Patients with COVID-19: A Multicenter Retrospective Cohort Study.
Microorganisms. 2022 May 8;10(5):984. doi: 10.3390/microorganisms10050984.
7
Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach.
Neurol Int. 2022 Apr 15;14(2):368-377. doi: 10.3390/neurolint14020030.
8
Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study.
Ann Intensive Care. 2021 Nov 26;11(1):159. doi: 10.1186/s13613-021-00951-0.
9
Treatment with Fluticasone Propionate Increases Antibiotic Efficacy during Treatment of Late-Stage Primary Pneumonic Plague.
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0127521. doi: 10.1128/AAC.01275-21. Epub 2021 Nov 15.
10
Assessment of 28-Day In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019: An International Cohort Study.
Crit Care Explor. 2021 Nov 5;3(11):e0567. doi: 10.1097/CCE.0000000000000567. eCollection 2021 Nov.
本文引用的文献
1
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.
JAMA. 2020 Oct 6;324(13):1317-1329. doi: 10.1001/jama.2020.17022.
2
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
JAMA. 2020 Oct 6;324(13):1307-1316. doi: 10.1001/jama.2020.17021.
3
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis.
JAMA. 2020 Oct 6;324(13):1330-1341. doi: 10.1001/jama.2020.17023.
4
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
JAMA. 2020 Oct 6;324(13):1298-1306. doi: 10.1001/jama.2020.16761.
5
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients.
Crit Care. 2020 Aug 12;24(1):495. doi: 10.1186/s13054-020-03218-5.
6
Dexamethasone in Hospitalized Patients with Covid-19.
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
7
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
8
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447. doi: 10.1001/jamainternmed.2020.3596.
9
Between-centre differences for COVID-19 ICU mortality from early data in England.
Intensive Care Med. 2020 Sep;46(9):1779-1780. doi: 10.1007/s00134-020-06150-y. Epub 2020 Jun 22.
10
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
Zotero 插件